Performance verification is the stage at which a lateral flow assay moves from development understanding to formal analytical evidence. This article explains how intended use and design inputs shape verification strategy, how CLSI-guided studies are structured, and why robust documentation is critical for transfer, submission, and product readiness.
This article explores sensitivity vs specificity in in vitro diagnostics, and how balancing both is critical for test performance, diagnostic accuracy, and reliable clinical decisions.